NCT00390299View on ClinicalTrials.gov

Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 23, 2006

Primary Completion Date

November 29, 2018

Study Completion Date

November 30, 2019

Conditions
Anaplastic AstrocytomaAnaplastic OligodendrogliomaMixed GliomaRecurrent Glioblastoma
Interventions
BIOLOGICAL

Carcinoembryonic Antigen-Expressing Measles Virus

Given via injection into resection cavity or around tumor bed and/or IT

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Therapeutic Conventional Surgery

Undergo en bloc resection

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER